Literature DB >> 33664397

Hepatic lymphocytes involved in the pathogenesis of pediatric and adult non-alcoholic fatty liver disease.

Victoria Cairoli1, Elena De Matteo1, Daniela Rios1, Carol Lezama2, Marcela Galoppo2, Paola Casciato3, Eduardo Mullen4, Cecilia Giadans1, Gustavo Bertot5, María Victoria Preciado1, Pamela Valva6.   

Abstract

The immune response is critical in NAFLD pathogenesis, but the liver infiltrate's composition and the role of each T cell population is still up for debate. To characterize liver pathogenesis in pediatric and adult cases, frequency and localization of immune cell populations [Cytotoxic T Lymphocytes (CD8+), T helper Lymphocytes (CD4+), Regulatory T lymphocytes (Foxp3+) and Th17 (IL-17A+)] were evaluated. In portal/periportal (P/P) tracts, both age groups displayed a similar proportion of CD8+ and CD4+ lymphocytes. However, comparable Foxp3+ and IL-17A+ cell frequencies were observed in pediatric cases, meanwhile, in adults Foxp3+ was higher than IL-17A+ cells. Interestingly, IL-17A+ lymphocytes seemed to be nearly exclusive of P/P area in both age groups. In intralobular areas, both pediatric and adult cases showed CD8+ lymphocytes predominance with lower frequencies of CD4+ lymphocytes followed by Foxp3+ . Severe inflammation was associated with higher intralobular Foxp3+ lymphocytes (p = 0.026) in children, and lower P/P Foxp3+ and higher IL-17A+ lymphocytes in adults. All cases with fibrosis ≥ 2 displayed P/P low Foxp3+ and high IL-17A+ lymphocyte counts. Pediatric cases with worse steatosis showed high P/P CD4+ (p = 0.023) and intralobular CD8+ (p = 0.027) and CD4+ cells (p = 0.012). In NAFLD cases, the lymphocyte liver infiltrate composition differs between histological areas. Treg and Th17 balance seems to condition damage progression, denoting their important role in pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33664397      PMCID: PMC7933421          DOI: 10.1038/s41598-021-84674-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  32 in total

1.  Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16,390 overweight or obese children and adolescents.

Authors:  S Wiegand; K-M Keller; M Röbl; D L'Allemand; T Reinehr; K Widhalm; R W Holl
Journal:  Int J Obes (Lond)       Date:  2010-06-08       Impact factor: 5.095

Review 2.  Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.

Authors:  Herbert Tilg; Alexander R Moschen
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

Review 3.  IL-17 and Th17 Cells.

Authors:  Thomas Korn; Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 4.  Interleukin-17 and type 17 helper T cells.

Authors:  Pierre Miossec; Thomas Korn; Vijay K Kuchroo
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

5.  Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.

Authors:  Mattias Ekstedt; Hannes Hagström; Patrik Nasr; Mats Fredrikson; Per Stål; Stergios Kechagias; Rolf Hultcrantz
Journal:  Hepatology       Date:  2015-03-23       Impact factor: 17.425

6.  The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis.

Authors:  Nazarena E Ferreyra Solari; María Eugenia Inzaugarat; Placida Baz; Elena De Matteo; Carol Lezama; Marcela Galoppo; Cristina Galoppo; Alejandra C Cherñavsky
Journal:  J Clin Immunol       Date:  2012-01-07       Impact factor: 8.317

7.  Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.

Authors:  Robert J Wong; Ramsey Cheung; Aijaz Ahmed
Journal:  Hepatology       Date:  2014-04-25       Impact factor: 17.425

Review 8.  The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease.

Authors:  Magdalena Świderska; Jerzy Jaroszewicz; Agnieszka Stawicka; Anna Parfieniuk-Kowerda; Adrian Chabowski; Robert Flisiak
Journal:  Clin Exp Hepatol       Date:  2017-06-21

9.  Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C coinfection.

Authors:  S K Williams; E Donaldson; T Van der Kleij; L Dixon; M Fisher; J Tibble; Y Gilleece; P Klenerman; A H Banham; M Howard; D P Webster
Journal:  J Viral Hepat       Date:  2013-08-15       Impact factor: 3.728

Review 10.  Liver immunology and its role in inflammation and homeostasis.

Authors:  Mark W Robinson; Cathal Harmon; Cliona O'Farrelly
Journal:  Cell Mol Immunol       Date:  2016-04-11       Impact factor: 11.530

View more
  5 in total

Review 1.  NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook.

Authors:  Alberto Nascè; Karim Gariani; François R Jornayvaz; Ildiko Szanto
Journal:  Antioxidants (Basel)       Date:  2022-06-09

Review 2.  Clinical perspectives on the age-related increase of immunosuppressive activity.

Authors:  Antero Salminen
Journal:  J Mol Med (Berl)       Date:  2022-04-06       Impact factor: 5.606

Review 3.  Fine-tuning of regulatory T cells is indispensable for the metabolic steatosis-related hepatocellular carcinoma: A review.

Authors:  Farooq Riaz; Ping Wei; Fan Pan
Journal:  Front Cell Dev Biol       Date:  2022-07-15

Review 4.  Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy.

Authors:  Chun-Ye Zhang; Shuai Liu; Ming Yang
Journal:  World J Gastroenterol       Date:  2022-07-21       Impact factor: 5.374

5.  Exploration of new therapeutic targets for viral hepatic fibrosis, alcoholic hepatic fibrosis, and non-alcoholic hepatic fibrosis.

Authors:  Xiaoling Wang; Ying Wang; Jun Xu; Jun Xie; Xuewei Li; Shuo Qin
Journal:  Ann Transl Med       Date:  2022-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.